Biotronik today shared preclinical results for its LivIQ leadless pacemaker system at Heart Rhythm Society (HRS) 2026 in ...

Wireless or leadless pacemakers, commonly implanted in adults, may be a safe and effective short-term option for children with slow heartbeats, according to new research published today in Circulation ...

Abbott (NYSE:ABT) today shared new study findings supporting its pulsed field ablation (PFA) and conduction system pacing ...

Please provide your email address to receive an email when new articles are posted on . The world’s first dual-chamber leadless pacing system has been approved by ...

Medtronic has secured the FDA’s approval for the latest generation of its miniaturized, wireless pacemaker implants, the Micra AV2 and VR2. According to the company, the newest models can offer up to ...

Just a few weeks after Abbott presented the successful results of a trial of its Aveir DR dual-chamber leadless pacemaker system—data that it said had been promptly submitted for regulatory review—the ...

Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...

Patients who received leadless pacemakers experienced fewer short-term and mid-term complications overall than those who had traditional transvenous pacemakers, a Cleveland Clinic-led research study ...

ABBOTT PARK, Ill., Nov. 12, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new, late-breaking data from the global Leadless II IDE study evaluating Abbott's investigational Aveir leadless ...

Leadless pacemaker technology represents a significant advancement in cardiac rhythm management, eliminating the need for transvenous leads and reducing many of the complications associated with ...

A new leadless dual-chamber pacemaker for patients with heart issues could be available later this year, according to new research published last week and funded by Abbott Medical. The U.S. Food and ...

The National Institute for Health and Care Excellence (NICE) has provisionally recommended leadless cardiac pacemaker implantation for patients with bradyarrhythmias who require single-chamber pacing.